Analysts expect Spruce Biosciences, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 602,000.00 | 700,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.66 M | 870,619.46 | 256,193.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.28 M | 11.64 M | 10.37 M | 5.66 M | ||||||||||
| Low Estimate | 1.51 M | 790,906.10 | 223,024.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.49 M | 10.71 M | 9.46 M | 5.24 M | ||||||||||
| Consensus Estimate | 1.59 M | 830,762.78 | 239,608.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.89 M | 11.18 M | 9.91 M | 5.45 M |
Analysts expect Spruce Biosciences, Inc. to report earnings per share of -5.93 for Q3 26, against a range of -6.31 to -5.55. The most recent reported quarter, Q2 26, came in at -6.68, a 20.1% miss against the -5.56 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -15.75 | -42.75 | -24.00 | -3.50 | -14.58 | -8.73 | -8.94 | -6.68 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -17.22 | -14.10 | -16.86 | -16.21 | -12.99 | -8.38 | -6.81 | -5.30 | -5.55 | -4.75 | -5.10 | -5.64 | -3.69 | -1.13 | -0.54 | -1.70 | ||||||||||
| Low Estimate | -19.42 | -16.34 | -20.48 | -18.15 | -14.07 | -9.02 | -7.99 | -5.82 | -6.31 | -5.61 | -6.02 | -6.50 | -4.09 | -1.21 | -0.62 | -2.08 | ||||||||||
| Consensus Estimate | -18.32 | -15.22 | -18.67 | -17.18 | -13.53 | -8.70 | -7.40 | -5.56 | -5.93 | -5.18 | -5.56 | -6.07 | -3.89 | -1.17 | -0.58 | -1.89 |
Pull Wall Street consensus for Spruce Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SPRB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SPRB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SPRB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();